20/20 Biolabs (AIDX) Earnings Analysis
20/20 Biolabs (AIDX) next reports earnings on 2026-09-02, consensus EPS -0.12 USD. Last quarter (2026-05-20) it missed with EPS -0.28 USD vs -0.1 USD est (-180%). It has beaten estimates in 0/1 recent quarters (0%). Trailing P/E -0.95.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AIDX next report earnings?
| Next earnings date | 2026-09-02 |
|---|---|
| Consensus EPS estimate | -0.12 USD |
| Revenue estimate | 0.00B |
AIDX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-20 | -0.28 USD | -0.1 USD | -180% | Miss |
| 2026-03-31 | -0.25 USD | n/a | n/a | n/a |
Beat rate: 0/1 (0%) over reported quarters with consensus data.
AIDX valuation and analyst view
| Trailing P/E | -0.95 |
|---|---|
| Trailing EPS | -0.56262 USD |
| Price / book | 1.52 |
| Dividend yield | 0.00% |
| Market cap | 0.00B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is 20/20 Biolabs (AIDX)'s next earnings date?
20/20 Biolabs is next scheduled to report on 2026-09-02, with a consensus EPS estimate of -0.12 USD and revenue estimate of 0.00B.
Did AIDX beat earnings last quarter?
In its 2026-05-20 report, AIDX posted EPS of -0.28 USD versus a -0.1 USD estimate — a miss of 180%.
What is AIDX's earnings track record?
Over the last 1 reported quarters with consensus data, AIDX beat estimates 0 times (0%).
What is AIDX's current P/E ratio and EPS?
AIDX trades at a trailing P/E of -0.95 on trailing EPS of -0.5626246779350598 USD.
What do analysts rate AIDX?
AIDX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.